PlainRecalls
ModerateClass IITerminated

FDA Drug recall · Reported December 18, 2019

Lidocaine HCl 2% 5 mL, Syringe, Rx Only, SCA Pharmaceuticals 755 Rainbow Road Windsor, CT 08695 NDC 70004-0723-09

Presence of Foreign Substance: Foreign material found inside the vial (manufacturer).

Recall #
D-0620-2020
Affected scope
1363 syringes
Initiated
November 26, 2019
Verify with FDA Drug →
View my saved recalls

Sca Pharmaceuticals, LLC recalled Lidocaine HCl 2% 5 mL, Syringe, Rx Only, SCA Pharmaceuticals 755 Rainbow Road Windsor, CT… - a moderate-severity action.

Lidocaine HCl 2% 5 mL, Syringe, Rx Only, SCA Pharmaceuticals 755 Rainbow Road Windsor, CT… was recalled by Sca Pharmaceuticals, LLC in December 18, 2019. Reason: Presence of Foreign Substance: Foreign material found inside the vial (manufacturer).. Check the official notice for the remedy. Verify recall #D-0620-2020 with the FDA Drug before acting.

The recall

Sca Pharmaceuticals, LLC issued this moderate-severity FDA Drug recall-Presence of Foreign Substance: Foreign material found inside the vial (manufacturer)..

Moderate
severity level
Class II
classification
December 18, 2019
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-0620-2020 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Medical Devices recalls over time

Where this recall sits in its category - 41,021 medical devices recalls on record

01,0002,0003,0004,000 20052008201120142017202020232026 1,947
Severity1906864652High severity (most serious)Moderate severityLow severity
Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

Lidocaine HCl 2% 5 mL, Syringe, Rx Only, SCA Pharmaceuticals 755 Rainbow Road Windsor, CT 08695 NDC 70004-0723-09

Reason for recall

Presence of Foreign Substance: Foreign material found inside the vial (manufacturer).

Recall Profile

Structured summary of the FDA Drug recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Moderate (Class II)
Status Terminated
Recall number D-0620-2020
Date reported December 18, 2019
Date initiated November 26, 2019
Recalling firm Sca Pharmaceuticals, LLC
Firm location Windsor, CT
Affected scope 1363 syringes
Distribution nationwide

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (D-0620-2020) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Drug before acting, recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
Lidocaine HCl 2% 5 mL, Syringe, Rx Only, SCA Pharmaceuticals 755 Rainbow Road Windsor, CT 08695 NDC 70004-0723-09. Recalled by Sca Pharmaceuticals, LLC. Units affected: 1363 syringes.
Why was this product recalled?
Presence of Foreign Substance: Foreign material found inside the vial (manufacturer).
Which agency issued this recall?
This recall was issued by the FDA Drug on December 18, 2019. Severity: Moderate. Recall number: D-0620-2020.
Where was the recalled product distributed?
Distribution: nationwide.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Compare this recall with GORE VIABIL Short Wire Biliary Endoprosthesis, Model No. VS… → · All Medical Devices recalls

This recall: FDA Drug, reported December 18, 2019. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026